Background: The interaction of environmental factors and genetic factors may contribute to the risk of type 2 diabetes (T2D). We aimed to investigate whether age, gender, body mass index (BMI) and lifestyle factors have an effect on the association between the CDKAL1 polymorphisms and T2D. Methods: Eight single nucleotide polymorphisms in CDKAL1 were genotyped by Agena MassARRAY in 508 T2D patients and 503 controls. The association between the CDKAL1 polymorphisms and T2D was evaluated using logistic regression model by calculating OR and 95% CIs. Results: We found a significant association between CDKAL1 polymorphisms (rs4712523, OR 1.42, p = 9.44 × 10 -5 ; rs4712524, OR 1.38, p = 3.28 × 10 -4 ; rs10946398, OR 1.43, p = 6.21 × 10 -5 ; rs7754840, OR 1.43, p = 6.33 × 10 -5 ; rs35612982, OR 1.34, p = 0.0010; and rs10440833, OR 1.32, p = 0.0018) and T2D risk among the Han population from Northwest China. We also found that genetic variants of CDKAL1 could modify the risk of T2D that might be influenced by age, BMI and the status of smoking and drinking. Besides, rs35612982-CT (p = 0.038) and rs10440833-AT (p = 0.044) genotypes were higher insulin level. Conclusion: CDKAL1 rs35612982 (C/T) polymorphism, as a new polymorphism, was associated with the increased risk of T2D in the Han Chinese population. Moreover, the contribution of CDKAL1 polymorphisms to T2D risk seems to be associated with age, gender, BMI, smoking and drinking.
Background
Type 2 diabetes (T2D) is a serious and common chronic metabolic disease characterized by insufficient insulin secretion leading to hyperglycaemia, and is a major life-threatening health problem throughout the world [1] . According to the World Health Organization in 2014, diabetes prevalence reached 422 million, with T2D accounting for more than 90% of these cases [2] . In China, the incidence of T2D in adults has been increasing over recent decades [3] . T2D is a complex, heterogeneous and multifactorial disorder caused by genetic and environmental factors such as obesity and unhealthy lifestyle [4] . Genetic susceptibility appears to have a crucial role in the aetiology and manifestation of the disease. Genome-wide association studies have pointed that some single nucleotide polymorphisms (SNPs) are important risk factors for T2D, which is associated with the mortality among diabetic patients [5, 6] .
CDKAL1 gene, mapped to chromosome 6p22.3, encodes cyclin-dependent kinase 5 regulatory subunit-associated protein 1 (CDK5RAP1)-like 1. CDK5 is a serine/threonine protein kinase, which contributed to the glucose-dependent regulation of the insulin secretion. CDK5 plays a permissive role in the glucotoxicity, the pathophysiology of β-cell dysfunction and predisposition to T2D [7] . CDKAL1 has the protein domain similarity with CDK5RAP1, which is a negative regulator of CDK5 through the inhibition of the CDK5 activator p35 [8] . CDKAL1 expression in human pancreatic beta-cells [9] supports the correlation of CDKAL1-and CDK5mediated pathways. Consistently, several studies showed the association of genetic variants in CDKAL1 with the defects in proinsulin conversion and insulin response upon glucose stimulation [10, 11] . Thus, CDKAL1 is a well-accepted pathogenesis-related key protein for T2D.
Genome-wide association studies have identified several SNPs in the CDKAL1 gene associated with T2D [12, 13] . A recent study has reported the significant association between CDKAL1 variants and susceptibility to T2D in Caucasian and Asian but not African populations [14] , indicating that the association is an ethnic difference. This necessitates the replicating the association of these variants with T2D risk in different ethnicities. Furthermore, whether there is the contribution of non-genetic factors in the association between CDKAL1 SNPs and T2D needs to be investigated.
Here, we conducted a case-control study to examine the effects of age, gender, body mass index (BMI), smoking and alcohol consumption, and CDKAL1 polymorphisms on the risk of T2D, and to explore the association of CDKAL1 SNPs with clinical characteristics among T2D patients in the Han population from Northwest China. Especially, there are no published reports assessing the role of CDKAL1 rs35612982 and rs10440833 variants in the susceptibility of T2D in a Chinese Han population.
Methods

Study Participants
A total of 508 T2D patients and 503 age-and gender-matched healthy controls with normal blood glucose levels were recruited from the First Affiliated Hospital of Xi'an Jiaotong University in this study. All recruited subjects were unrelated ethnic Han Chinese. All patients were newly diagnosed with T2D based on fasting plasma glucose ≥7.0 mmol/L and⁄or postprandial plasma glucose ≥11.1 mmol/L, in keeping with the WHO criteria [15] . Patients with type 1 diabetes mellitus, gestational diabetes, acute or chronic diseases of the liver, kidney, or heart or other endocrine disease, inflammatory diseases, or malignant tumours were excluded. Healthy individuals with a normal fasting glucose level and without history of T2D and other chronic diseases were recruited as controls. This case-control study was carried out with the approval of the Ethics Committee of the First Affiliated Hospital of Xi'an Jiaotong University and in accordance with the guidelines of the Declaration of Helsinki. All participants were informed about the purpose of this study and signed a written informed consent.
DNA Isolation and Genotyping
The peripheral blood (5 mL) of all the subjects was collected in EDTA-coating tubes. The epidemiological and clinical data were collected with a questionnaire and medical records. The following data were recorded: age, gender, BMI (kg/m 2 ), smoking habits, alcohol consumption, and clinical parameters. Genomic DNA was isolated from peripheral blood leukocytes by GoldMag DNA Purification Kit (GoldMag Co. Ltd., Xi'an, China), quantified by NanoDrop 2000 (Thermo Scientific, Waltham, MA, USA), then stored at -20 ° C for further analysis.
Eight CDKAL1 SNPs (rs4712523, rs4712524, rs10946398, rs7754840, rs7756992, rs35612982, rs10440833 and rs6931514) were selected based on diabetes-related polymorphisms reported by previous GWAS studies, the NCBI SNP database (https://www.ncbi.nlm. nih.gov/snp/), and minor allele frequencies > 5% in the 1000 Genomes Project data (http:// www.internationalgenome.org/). The potential function CDKAL1 polymorphisms were estimated by HaploReg version 4.1 (https://pubs.broadinstitute.org/mammals/haploreg/ haploreg.php). Genotyping was performed using Agena MassARRAY system (Agena, San Diego, CA, USA) according to the manufacturer's instructions [16, 17] . The primers for PCR amplification and single base extension were shown in online supplementary Table 1 (for all online suppl. material, see www.karger.com/doi/10.1159/000503175). Cases and controls were randomized during genotyping. Approximately 5% of the samples were genotyped in duplicate, and the concordance was 100%.
Statistical Analysis
All data were analyzed by SPSS version 18.0 (SPSS Inc., Chicago, IL, USA) and PLINK software. Student t test or chi-square test was used to compare the difference of characteristics between T2D patients and healthy controls. Demographic and clinical variables were reported as mean (SD) for continuous variables and frequency (percentage) for categorical variables. Hardy-Weinberg equilibrium in controls was determined via a goodness-of-fit χ 2 test. ORs and 95% CIs for multiple inheritance models (allelic, genotype, dominant, recessive and log-additive) were calculated by χ 2 and logistic regression analysis to estimate the relationship between CDKAL1 polymorphisms and T2D susceptibility. Bonferroni method was used to correct for multiple comparisons in the overall subjects. Pairwise linkage disequilibrium (LD) and haplotype analyses were analyzed using Haploview (version 4.2) and PLINK software. A two-tailed p value < 0.05 was considered statistically significant, whereas a value of corrected p < 0.05/(8 × 5) was considered significant after Bonferroni correction.
Meta-Analysis
A comprehensive search in PubMed, Embase, and the China National Knowledge Infrastructure databases was conducted using the following search terms: "CDKAL1," "rs10946398," "rs7754840" and "T2D" up to March of 2019. The articles selected for the subsequent metaanalysis were all published in English in the primary literature. For rs10946398 [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] and Bold indicate that p < 0.05 indicates statistical significance. T2D, type 2 diabetes; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; ALBP, adipocyte lipid-binding protein; GFR, glomerular filtration rate; CRP, C-reactive protein INS, insulin; 25QWD, 25 hydroxy-vitamin D; UCRP, ubiquitin cross-reactive protein; RBP, retinol-binding protein. rs7754840 [20, 22, 29, [31] [32] [33] [34] [35] [36] [37] [38] [39] , we found 13 and 12 articles respectively. STATA version 11.0 (Stata Corporation, TX, USA) was used to analysis the association of CDKAL1 10946398 and rs7754840 variants with the risk of T2D. The pooled OR in the allele model was assessed by the Z-test, and p < 0.05 was considered statistical significance. The pooled OR was calculated by a random-effects model if I 2 > 50% or P Q < 0.1, which indicated heterogeneity was significant; otherwise, the pooled OR was assessed by a fixed-effects model [40] .
Results
A total of 508 T2D patients (277 males and 231 females, mean age 59.21 [11.90] ) and 214 healthy controls (279 males and 224 females, mean age 59.34 [7. 62]) were recruited. Table  1 displayed the clinical and biochemical characteristics of the participants in detail. There was no significant difference in the distribution of gender and age between T2D patients and the healthy controls (p = 0.841 and 0.712 respectively). The level of total cholesterol (p = 0.029) and GFR (p < 0.001) differed significantly between the T2D group and the normoglycaemic health control group.
Logistic regression analysis was used to assess the relationship between the susceptibility of T2D and confounding factors. We found that BMI > 24 kg/m 2 (OR 1.57, 95% CI 1.09-2.25, p = 0.014) was significantly associated with a higher risk for T2D, while drinking (OR 0.25, 95% CI 0.15-0.42, p < 0.001) showed a significant negative association with T2D ( Table 2 ).
The detailed information of candidate SNPs in CDKAL1 was listed in Table 3 . The minor allele frequencies of these SNPs were > 5%, and all SNPs were in accordance with Hardy-Weinberg equilibrium among the controls (p > 0.05). Results of allele model showed that 6 SNPs in CDKAL1 were significantly associated with increased T2D risk with overall effects (OR) from 1.34 to 1.43 (rs4712523, OR 1.42, 95% CI 1.19-1.69, p = 9.44 × 10 -5 ; rs4712524, OR 1.38, 95% CI 1.16-1.65, p = 3.28 × 10 -4 ; rs10946398, OR 1.43, 95% CI 1.20-1.71, p = 6.21 × 10 -5 ; rs7754840, OR 1.43, 95% CI 1.20-1.71, p = 6.33 × 10 -5 ; rs35612982, OR 1.34, 95% CI 1.12-1.60, p = 0.0010; and rs10440833, OR 1.32, 95% CI 1.11-1.58, p = 0.0018). Considering multiple comparisons, we used Bonferroni correction on the results and p < 0.05/(8 × 5) was considered significant threshold. The significance between CDKAL1 polymorphisms (rs4712523, rs4712524, rs10946398, rs7754840, and rs35612982) still existed after Bonferroni correction.
The genotype frequencies of CDKAL1 polymorphisms were shown in Table 4 and online supplementary Table 2 . Among these variants, the genotype frequencies containing "two" risk alleles of rs4712523, rs4712524, rs10946398 and rs7754840 variants were significantly different between case and control groups (p < 0.05). After Bonferroni correction, rs4712523 and rs4712524 polymorphisms were associated with the significant susceptibility to T2D under homozygote and additive models (rs4712523: OR 1.97, p = 1.49 × 10 -4 and OR 1.40, p = 1.43 × 10 -4 ; rs4712524, OR 1.85, p = 5.85 × 10 -4 and OR 1.36, p = 4.85 × 10 -4 ; Table 4 ). Rs10946398 (homozygote: OR 2.03, p = 8.89 × 10 -5 ; recessive: OR 1.67, p = 9.91 × 10 -4 ; and additive: OR 1.42, p = 9.04 × 10 -5 ) and rs7754840 (homozygote: OR 2.03, p = 9.07 × 10 -5 ; recessive: OR 1.68, p = 9.37 × 10 -4 ; and additive: OR 1.42, p = 9.39 × 10 -5 ) variants had a higher risk for T2D after Bonferroni correction. In addition, rs35612982 (OR 1.78, p = 0.0014; OR 1.40, p = 0.0121; OR 1.54, p = 0.0062 and OR 1.33, p = 0.0015) and rs10440833 (OR 1.75, p = 0.0020; OR 1.38, p = 0.0190; OR 1.53, p = 0.0070 and OR 1.31, p = 0.0022). SNPs also contributed to the increased T2D risk under multiple genetic models, while the significance was lost when Bonferroni correction was conducted. However, there was no statistically significant association between other 2 SNPs (rs7756992 and rs6931514) and T2D risk (p > 0.05, online suppl. Table 2 ).
We next conducted LD and haplotype analyses of CDKAL1 polymorphisms. Figure 1 revealed the existence of 2 LD blocks in CDKAL1 SNPs (Block 1: rs4712523, rs4712524, rs10946398 and rs7754840; Block 2, rs7756992, rs35612982, rs10440833 and rs6931514). The frequencies of haplotypes in the case and control groups were presented in Table 5 . The haplotypes "GGCC" (OR 1.42, p = 9.39 × 10 -5 ) and "AAAG" (OR 1.36, p = 5.33 × 10 -4 ) in block 1 and "ATTA" (OR 1.33, p = 0.0013) and "GCAG" (OR 1.55, p = 0.0084) in block 2 were significantly associated with the higher risk of T2D after being adjusted by age and gender.
We further analyzed whether the genotypic effects on T2D risk were dependent on gender and age (online suppl. Table 3 ). We found that rs4712523, rs4712524, rs10946398, rs7754840, rs35612982 and rs10440833 variants were associated with an increased risk of T2D in both males and females (p < 0.05). Rs4712523, rs10946398, and rs7754840 polymorphisms were at higher risk of developing T2D in subjects at age > 59 years or at age ≤59 years (p < 0.05). Interestingly, associations between CDKAL1 SNPs (rs4712524, rs35612982 and rs10440833) and the increased risk of T2D were found only among participants younger than 59 years of age.
We further examined whether BMI, smoking and drinking status had an effect on the association of CDKAL1 polymorphisms with T2D risk. As shown in online supplementary Table 4 , we also found that rs4712523, rs4712524, rs10946398, rs7754840, rs35612982 and rs10440833 variants had increased risk of developing T2D in subgroup with BMI > 24 kg/ m 2 , non-smokers and non-drinking (p < 0.05). Moreover, the significant associations between rs35612982 and rs6931514 polymorphisms and T2D susceptibility were observed only in non-smokers (p < 0.05).
To evaluate the effect of diabetes duration and retinopathy, T2D patients were divided into 2 groups according to diabetes duration and retinopathy (online suppl. Table 5 ). Rs4712523 (OR 1.84, p = 0.0281), rs10946398 (OR 1.81, p = 0.0332) and rs7754840 (OR 1.81, p = 0.0332) variants in CDKAL1 were found to be associated with the increased risk of T2D with retinopathy. However, no significant correlation was found in diabetes duration.
The relation between the genotypes of CDKAL1 SNPs and the biochemical indexes in T2D patients was investigated. As shown in Table 6 and online supplementary Table 6 , the urea levels for different genotypes of rs7756992 (p = 0.003), rs35612982 (p = 0.015), rs10440833 (p = 0.015) and rs6931514 (p = 0.005) had a significant difference. A significant association was observed between CDKAL1 rs7756992 and rs6931514 genotypes and the levels of creatinine (p = 0.045 and p = 0.037, respectively). Besides, rs35612982-CT (p = 0.038) and rs10440833-AT (p = 0.044) genotypes had a higher insulin level. However, there was no difference in the remaining lipid parameters among the genotypes of the selected SNPs (p > 0.05 for all). Bold values indicate that p < 0.05 indicates statistical significance. The block 1 comprises the 4 closely linked SNPs rs4712523, rs4712524, rs10946398 and rs7754840. The block 2 comprises the 4 closely linked SNPs rs7756992, rs35612982, rs10440833 and rs6931514. p values were calculated using logistic regression analysis with and without adjustment by gender and age.
SNP, single nucleotide polymorphism; T2D, type 2 diabetes.
Discussion
In this study, we found significant associations between CDKAL1 polymorphisms (rs4712523, rs4712524, rs10946398, rs7754840, rs35612982 and rs10440833) and T2D risk among the Han population from Northwest China. Specially, this study first provided evidence for the remarkable contribution of CDKAL1 rs35612982 and rs10440833 to T2D susceptibility in the Chinese Han population. More interestingly, we found that genetic variants of CDKAL1 could affect the risk of T2D not only by itself but also by associating with age, BMI and the status of smoking and drinking. Besides, rs35612982-CTand rs10440833-ATgenotypes had a higher insulin level.
CDKAL1 gene is regarded as T2D susceptibility gene involved in glucose regulation and insulin secretion/action [41] . CDKAL1 variants were related with defects in proinsulin conversion and insulin response upon glucose stimulation [42] . Several studies have provided evidence for the significant contribution of CDKAL1 polymorphisms to T2D risk [35, 43, 44] . Consistent with previous reports, CDKAL1 variants (rs4712523, rs4712524, rs10946398, rs7754840) were associated with T2D susceptibility in the Chinese Han population. Moreover, our results first found that rs35612982 and rs10440833 polymorphisms conferred to the increased risk of T2D among the Chinese Han population, especially rs35612982 polymorphism that has not been reported. This result suggests that the CDKAL1rs35612982 variant might play an important role in the pathogenesis of T2D. Previously, Lu et al. [43] suggested that rs6931514 and rs7756992 were associated with increased T2D risk in Chinese populations. However, there was no association of rs6931514 and rs7756992 with the risk of T2D in our study. A global meta-analysis also revealed that no association for the SNP rs7756992 was found in the Asian population [45] . Such inconsistencies in these reports may result from different environmental conditions or insufficient sample size. Genetic and environmental factors are interrelated and contribute to the development of T2D. Age, obesity, and unhealthy lifestyle identify those individuals at highest risk of T2D [46] . Interestingly, we found that rs4712524, rs35612982 and rs10440833 variants contributed the increased T2D risk at age ≤59 not > 59 years, suggesting that the risk association might be age dependent. Overweight and obesity (defined by BMI) is a known risk factor for T2D [47] . We found that BMI > 24 kg/m 2 was associated with increased risk of T2D. Stratified by BMI, we found that CDKAL1 polymorphisms (rs4712523, rs4712524, rs10946398, rs7754840, rs35612982 and rs10440833) were associated with the increased susceptibility to T2D in the overweight/obese (BMI > 24 kg/m 2 ) population. Smoking and drinking (especially heavy alcohol consumption) are known risk factors for diabetes.
Smoking increases the risk of T2D by 30-40% for active smokers compared to non-smokers [48] . It has been found that cigarette smoking and alcohol consumption are related to glycaemic control and insulin resistance [49, 50] . However, drinking might have a reduced T2D risk, while smoking had no association with T2D in our study. In addition, our results revealed that CDKAL1 polymorphisms increased the risk of T2D among those non-smokers and non-drinkers. The effect of smoking and drinking on the association between CDKAL1 polymorphisms and the susceptibility of T2D are required to validate the results in larger populations and in laboratory-based functional experiments. However, the limitations of the present study should not be ignored. First, the subjects were enrolled from identical hospitals; therefore, they may not be representative of the general population. Second, the potential function of these SNPs in the aetiology of T2D was still unknown; thus, genetic and functional analyses were urgently required to reveal the precise role of these polymorphisms in T2D.
Conclusions
In conclusion, the present study identified the CDKAL1 rs35612982 (C/T) polymorphism, as a novel polymorphism, associated with T2D in the Han population from Northwest China. Our study might help to enhance the understanding of CDKAL1 gene mutations in the pathogenesis of T2D. Further studies are needed to evaluate the functional and epidemiological importance of the rs35612982 polymorphism in T2D.
